Patents by Inventor Pyeong-Hwa Jeong

Pyeong-Hwa Jeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancer
    Patent number: 11370779
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancer, comprising, as an active ingredient, an indirubin derivative. When the compound of the present invention is used, it can effectively inhibit the activity of FLT3 kinase and can be usefully used to prevent or treat acute myeloid leukemia or metastatic breast cancer.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: June 28, 2022
    Assignee: PELEMED CO., LTD.
    Inventors: Yong Chui Kim, Pyeong-Hwa Jeong
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ACUTE MYELOID LEUKEMIA OR METASTATIC BREAST CANCER
    Publication number: 20200270229
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancer, comprising, as an active ingredient, an indirubin derivative. When the compound of the present invention is used, it can effectively inhibit the activity of FLT3 kinase and can be usefully used to prevent or treat acute myeloid leukemia or metastatic breast cancer.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 27, 2020
    Applicant: PELEMED CO., LTD.
    Inventors: Yong Chul Kim, Pyeong-Hwa Jeong